References
- 1. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations, International Forum of Acute Care Trialists. Am J Respir Crit Care Med. 2016; 193(3):259-72. DOI: 10.1164/rccm.201504-0781OC10.1164/rccm.201504-0781OC
- 2. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8): 801-10. DOI: 10.1001/jama.2016.028710.1001/jama.2016.0287
- 3. James D. Faix. Biomarkers of sepsis Crit Rev Clin Lab Sci, 2013; 50(1): 23-36. DOI: 10.3109/10408363.2013.76449010.3109/10408363.2013.764490
- 4. Christaki E, Anyfanti P, Opal SM. Immunomodulatory therapy for sepsis: an update. Expert Rev Anti Infect Ther 2011; 9:1013-33. DOI: 10.1586/eri.11.12210.1586/eri.11.122
- 5. László I, Trásy D, Molnár Z. Sepsis: From Pathophysiology to Individualized Patient Care, J Immunol Res. 2015; 2015: 510436. DOI: 10.1155/2015/51043610.1155/2015/510436
- 6. Sørensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318:727-32. DOI: 10.1056/NEJM19880324318120210.1056/NEJM198803243181202
- 7. Matthew J, Delano, Peter A. The Immune System’s Role in Sepsis Progression, Resolution and Long-Term Outcome. Immunol Rev. 2016; 274(1): 330-53. DOI: 10.1111/imr.1249910.1111/imr.12499
- 8. Fiedler U, Augustin HG: Angiopoietins: A link between angiogenesis and inflammation. Trends Immunol 2006; 27:552-58. DOI: 10.1016/j.it.2006.10.00410.1016/j.it.2006.10.004
- 9. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angio-genesis. Science 1997; 277:55-60. DOI: 10.1126/science.277.5322.5510.1126/science.277.5322.55
- 10. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, et al: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angio-genesis. Cell 1996; 87:1171-80. DOI: 10.1016/S0092-8674(00)81813-910.1016/S0092-8674(00)81813-9
- 11. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C: Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005; 111: 97-105. DOI: 10.1161/01.CIR.0000151287.08202.8E10.1161/01.CIR.0000151287.08202.8E
- 12. Parikh SM, Mammoto T, Schultz A, Yuan HT, Chris-tiani D, Karumanchi SA et al: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:356-70. DOI: 10.1371/journal.pmed.003004610.1371/journal.pmed.0030046
- 13. Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP et al. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res. 2001 Feb 16; 49(3):659-70. DOI: 10.1016/S0008-6363(00)00231-510.1016/S0008-6363(00)00231-5
- 14. Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, Griffiths J et al. Angiopoietin-2 functions as an auto-crine protective factor in stressed endothelial cells. Proc Natl Acad Sci U S A. 2006 Oct 17; 103(42):15491-6. DOI: 10.1073/pnas.060753810310.1073/pnas.0607538103159253417030814
- 15. MarikP.E, Taeb A.M. SIRS, qSOFA and new sepsis definition. J Thorac Dis. 2017; 9(4): 943-45. DOI: 10.21037/jtd.2017.03.12510.21037/jtd.2017.03.125541829828523143
- 16. Szederjesi J, Georgescu AM, Santini A, Almasy E, Lazar A, Hutanu A, et al. L. Ang-2, Tie-2 si Ang-2/Tie-2 ratio serum levels as diagnostic and prognostic bio-markers of sepsis in critically ill patients. Rev Romana Med Lab, 2016; 24:187-99. DOI: 10.1515/rrlm-2016-000710.1515/rrlm-2016-0007
- 17. Bányász I, Bokodi G, Vannay A, Szebeni B, Treszl A, Vásárhelyi B, et al. Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. Curr Eye Res. 2006; 31(7-8):685-90. DOI: 10.1080/0271368060080112310.1080/0271368060080112316877277
- 18. Parikh SM. Dysregulation of the angiopoietin-Tie2 axis in sepsis and ARDS. Virulence. 2013; 4:517-24. DOI: 10.4161/viru.2490610.4161/viru.24906535973723652985
- 19. Georgescu AM, Bănescu C, Badea I, Moldovan V, Huțanu A, Voidăzan S et al. IL-6 gene polymorphisms and sepsis in ICU adult Romanian patients: a prospective study. Rev Romana Med Lab, 2017; 25:75-89. DOI: 10.1515/rrlm-2016-004410.1515/rrlm-2016-0044
- 20. Tomescu DR, Dima OS, Ungureanu D, Popescu M, Tulbure D, Popescu I. First report of cytokine removal using CytoSorb® in severe noninfectious inflammatory syndrome after liver transplantation. Int J Artif Organs 2016; 16; 39(3):136-40. DOI: 10.5301/ijao.500048910.5301/ijao.500048927079418
- 21. Bataille A, Galichon P, Ziliotis M, Iman S, Hertig A. Epigenetic changes during sepsis: on your marks! Crit Care. 2015; 19: 358. DOI: 10.1186/s13054-015-1068-510.1186/s13054-015-1068-5460649526467433
- 22. Szederjesi J, Almasy E, Lazar A, Huțanu A, Georgescu A. The Role of Angiopoietine-2 in the Diagnosis and Prognosis of Sepsis. The Journal of Critical Care Medicine 2015; 1(1):18-23. DOI: 10.1515/jccm-2015-000410.1515/jccm-2015-0004595328029967811
- 23. Georgescu AM, Szederjesi J, Dobreanu M, Copotoiu SM, Voidăzan S, Huțanu A, et al. Soluble urokinase-type plasminogen activator receptor (suPAR) - a possible biomarker for bacteremia in sepsis. Rev Romana Med Lab, 2015; 23(1):59-73. DOI: 10.1515/rrlm-2015-000210.1515/rrlm-2015-0002
- 24. Corrêa TD, Sanches PR, de Morais LC, Scarin FC, Silva E, Barbas CS et al. Performance of noninvasive ventilation in acute respiratory failure in critically ill patients: a prospective, observational, cohort study. BMC Pulm Med. 2015; 15:144. DOI: 10.1186/s12890-015-0139-310.1186/s12890-015-0139-3464276626559350
- 25. Vincent JL, Opal SM, Marshall JC. Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med. 2010; 38:283-7. DOI: 10.1097/CCM.0b013e-3181b785a210.1097/CCM.0b013e3181b785a2
- 26. Sutherland A, Thomas M, Brandon RA, Brandon RB, Lipman J, Tang B et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit. Care. 2011; 15:R149. DOI: 10.1186/cc1027410.1186/cc10274321902321682927
- 27. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profiling of peripheral blood mononu-clear cells in sepsis. Crit. Care Med. 2009; 37:882-8. DOI: 10.1097/CCM.0b013e31819b52fd10.1097/CCM.0b013e31819b52fd19237892
- 28. Werner JA, Schierding W, Dixon D, MacMillan S, Oppedal D, Muenzer J, et al. Preliminary evidence for leukocyte transcriptional signatures for pediatric ventilator-associated pneumonia. J. Intensive Care Med. 2012; 27(6):362-9. DOI: 10.1177/088506661140683510.1177/088506661140683521606059
- 29. Dobreanu M, Oprea OR. Laboratory medicine in the era of precision medicine - dream or reality?. Rev Romana Med Lab. 2019;27(2):115-24. DOI: 10.2478/rrlm-2019-002510.2478/rrlm-2019-0025
- 30. Lazăr A, Georgescu AM, Vitin A, Azamfirei L. Precision Medicine and its role in the treatment of sepsis: a personalised view. Journal of Critical Care Medicine, 2019; 5:90-6. DOI: 10.2478/jccm-2019-001710.2478/jccm-2019-0017669807431431921
- 31. Johnson SB, Lissauer M, Bochicchio GV Moore R, Cross AS, Scalea TM.. Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann. Surg; 2007; 245:611-21. DOI: 10.1097/01. sla.0000251619.10648.3210.1097/01
- 32. Reinhart K, Bauer,M, Riedemann N.C, New approaches to sepsis: molecular diagnostics and Biomarkers. Clin Microbiol Rev. 2012; 25(4): 609-34. DOI: 10.1128/CMR.00016-1210.1128/CMR.00016-12348575123034322
- 33. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Eng J Med. 1999; 340:448-54. DOI: 10.1056/NEJM19990211340060710.1056/NEJM1999021134006079971870
- 34. Hofer N, Zacharias E, Muller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012; 102:25-36. DOI: 10.1159/00033662910.1159/00033662922507868
- 35. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004; 39:206-17. DOI: 10.1086/42199710.1086/42199715307030
- 36. Szederjesi J, Almasy E, Lazăr A, Huțanu A, Badea I, Georgescu A. C. Biomarkers of Severe Sepsis. J Crit Care Med 2015;1(4): 147-53. DOI: 10.1515/jccm-2015-002210.1515/jccm-2015-0022595329529967823